Key result
Cardiovascular disease is a frequent cause of morbidity and mortality in breast cancer survivors, mainly due to cardiotoxic drugs and radiotherapy, requiring multidisciplinary cardio-oncology care.
Why the study?
Cardiovascular disease is a frequent cause of morbidity and mortality in breast cancer patients, driven by shared risk factors, cardiotoxic drugs, and radiotherapy.
This review highlights the critical need for cardiovascular risk stratification, cardioprotection, and multidisciplinary cardio-oncology care for women with breast cancer to mitigate treatment-induced cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Supports heightened CVD vigilance in breast cancer survivors; leaves open optimal cardio-oncology protocols for prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Puente-Barragán et al. (2024) conducted a review in Breast cancer and cardiovascular disease. Antineoplastic therapy (chemotherapy and radiotherapy) was evaluated. Cardiovascular disease is a frequent cause of morbidity and mortality in breast cancer survivors, mainly due to cardiotoxic drugs and radiotherapy, requiring multidisciplinary cardio-oncology care.
Synapse has enriched 10 related papers. Consider them for comparative context: